Carnevale Carmela, Riva Ivano, Roberti Gloria, Michelessi Manuele, Tanga Lucia, Verticchio Vercellin Alice C, Agnifili Luca, Manni Gianluca, Harris Alon, Quaranta Luciano, Oddone Francesco
IRCCS-Fondazione Bietti, Rome, Via Livenza, 3, 00198 Rome, Italy.
Department of Surgical & Clinical, Diagnostic and Pediatric Sciences, Section of Ophthalmology, University of Pavia-IRCCS Fondazione Policlinico San Matteo, 27100 Pavia, Italy.
Pharmaceuticals (Basel). 2021 Jun 18;14(6):581. doi: 10.3390/ph14060581.
Glaucoma patients often suffer from ocular surface disease (OSD) caused by the chronic administration of topical anti-glaucoma medications, especially in cases of long-term therapy with preserved or multiple drugs. Additionally, glaucoma surgery may determine ocular surface changes related to the formation and location of the filtering bleb, the application of anti-mitotic agents, and the post-operative wound-healing processes within the conjunctiva. Recently, several studies have evaluated the role of advanced diagnostic imaging technologies such as in vivo confocal microscopy (IVCM) and anterior segment-optical coherence tomography (AS-OCT) in detecting microscopic and macroscopic features of glaucoma therapy-related OSD. Their clinical applications are still being explored, with recent particular attention paid to analyzing the effects of new drug formulations and of minimally invasive surgical procedures on the ocular surface status. In this review, we summarize the current knowledge about the main changes of the ocular surface identified at IVCM and AS-OCT in glaucoma patients under medical therapy, or after surgical treatment.
青光眼患者常因长期局部使用抗青光眼药物而患有眼表疾病(OSD),尤其是在长期使用单一或多种药物治疗的情况下。此外,青光眼手术可能导致与滤过泡的形成和位置、抗有丝分裂药物的应用以及结膜内术后伤口愈合过程相关的眼表变化。最近,多项研究评估了先进诊断成像技术,如活体共聚焦显微镜检查(IVCM)和眼前节光学相干断层扫描(AS-OCT)在检测青光眼治疗相关眼表疾病的微观和宏观特征方面的作用。它们的临床应用仍在探索中,最近特别关注分析新药物制剂和微创手术对眼表状态的影响。在这篇综述中,我们总结了目前关于在药物治疗或手术治疗后的青光眼患者中,通过IVCM和AS-OCT所识别出的眼表主要变化的知识。